Jonathan Wygant

Alere, Inc. engages in developing, manufacturing, and marketing consumer and professional medical diagnostic products. It operates through the following segments: Professional Diagnostics, Consumer Diagnostics, and Other Non-Reportable. The Professional Diagnostics segment includes an array of diagnostic test products and other in vitro diagnostic tests. The Consumer Diagnostics segment consists of manufacturing operations. The Other Non-Reportable segment includes Alere Home Monitoring, which distributes PT and INR coagulation; monitors and facilitates the distribution of equipment; and supplies to power and control customers' implanted ventricular assist devices and VADs. It also provides telemonitoring services that allow VAD coordinators to monitor patients soon after discharge and receive alerts when critical patient values fall outside pre-established ranges. The company was founded by Ronald Zwanziger on May 11, 2001 and is headquartered in Abbott Park, IL.

CareFusion 303, Inc. designs, makes and distributes infusion therapy and vital signs measurement instruments. The company operates manufacturing facilities in the United States, Mexico and the United Kingdom. The firm was founded in 1988 and is headquartered in San Diego, CA.

PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY.

CareFusion Corp. engages in the manufactures of medical equipment and device. The company was founded on February 4, 2009 and is headquartered in San Diego, CA.

Cibus Ltd. is a biotechnology company, which engages in the research and development of plant gene editing technology. It focuses on the commercialization of proprietary gene-editing technology, which refer to as the Rapid Trait Development System (RTDS). The RTDS enables to introduce customizable, specific, and predictable value-enhancing traits into plants and microorganisms. The company was founded in 2001 and is headquartered in San Diego, CA.

Cibus Corp. engages in the development of plant and microbial platforms. Its focuses in inputting traits and agronomic traits in canola, rice, soybean, corn, and wheat crops. The company was founded by Peter Beetham, Greg Gocal, Keith Walker, and Rory Riggs in 2001 and is headquartered in San Diego, CA.

Biosplice Therapeutics, Inc. provides medical research and development for tissue-level regeneration. It develops therapeutics to address a range of degenerative diseases, regenerative medicine and oncology. The company was founded by Osman Kibar and John Hood in 2008 and is headquartered in San Diego, CA.